newsfilter
← Latest News
GlobeNewswire·

Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update

Avicanna's evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna's 2025 advances across R&D, clinical development, and medical affairs. TORONTO, Dec. 19, 2025 (GLOBE